Matheson Advises On The Sale Of US Biotech Firm Dyax To UK-Listed Shire

Profession:Matheson
 
FREE EXCERPT

Matheson advised US biotech firm Dyax on Irish tax matters relating to its US$5.9 billion sale to Shire, the UK-listed pharmaceutical company.  The acquisition is intended to enhance Shire's position in treating rare genetic diseases.

The...

To continue reading

REQUEST YOUR TRIAL